Key takeaway: Neuropsychiatric SLE has no single confirmatory test—MRI, CSF, and EEG can support the diagnosis, but boards expect you to recognize it as a diagnosis of exclusion/attribution.
A 46-year-old female with a history of systemic lupus erythematosus has been lost to follow-up. Apparently, she has failed to fill her medications and has not been keeping up with her appointments. The daughter believes the patient has been using illicit drugs. She comes with a fever of 39°C, severe frontal headaches, confusion, and paranoid ideation. Her laboratory test results show leukopenia, hypocomplementemia and an elevated anti-double-stranded DNA antibody.
Which of the following is a confirmatory test for lupus cerebritis?
Examinees often want one “slam-dunk” study (e.g., MRI or CSF) to confirm neuropsychiatric lupus. The point this question tests is that while MRI abnormalities, inflammatory CSF (pleocytosis/protein), and EEG changes are common, they are nonspecific and can overlap with infection (meningoencephalitis), toxin/drug effects, primary psychiatric disease, metabolic encephalopathy, and cerebrovascular events (including antiphospholipid-related thrombosis). Contemporary consensus and society guidance treat neuropsychiatric SLE as a multimodal diagnosis based on clinical syndrome + supportive studies + exclusion of alternative etiologies rather than a single confirmatory test.
Therefore, E (None of the above) remains the most board-reliable answer: these tests are evaluative/supportive, not confirmatory.
| Option | What It Tests / Implies | Why It’s Wrong Here |
|---|---|---|
| A. CT scan of the head | Rapid rule-out of hemorrhage/mass | Helpful in acute evaluation, but typically insensitive for NPSLE and not confirmatory. |
| B. MRI of the brain | Best imaging for inflammatory/ischemic lesions | Can support NPSLE (white matter lesions, infarcts), but findings are nonspecific and may reflect APS stroke, infection, or other pathology. |
| C. Lumbar puncture | CSF pleocytosis/protein; rule out infection | CSF can be abnormal in NPSLE but also in infection; LP is for exclusion and supportive data, not confirmation. |
| D. EEG | Encephalopathy/seizure tendency | Nonspecific diffuse slowing or epileptiform activity does not confirm NPSLE. |
| E. None of the above | Recognizes lack of a single confirmatory test | Correct: diagnosis is clinical + supportive testing + exclusion of alternatives. |
For neuropsychiatric lupus, MRI/CSF/EEG are supportive and primarily help exclude mimics—none is confirmatory.
The stem “hands you” active SLE (low complement, high anti-dsDNA) and neuropsychiatric symptoms, tempting you to pick the most sophisticated test (MRI). But the word confirmatory is the trap: boards reward recognizing that NPSLE is diagnosed through pattern recognition plus exclusion, not a single definitive study.
A 28-year-old woman with SLE on prednisone and mycophenolate presents with fever, headache, photophobia, and confusion. Which test is most urgent to help exclude a key alternative diagnosis before attributing symptoms to NPSLE?
A 40-year-old woman with SLE develops sudden right-sided weakness and aphasia. MRI shows an acute left MCA infarct. Which additional finding most strongly supports antiphospholipid syndrome as the mechanism rather than inflammatory NPSLE?
A 33-year-old woman with SLE has agitation, paranoia, and insomnia starting 5 days after a prednisone dose increase to 60 mg/day. Afebrile; normal complement and stable anti-dsDNA. Most likely explanation?
A 45-year-old with known SLE presents with fever, confusion, and headache. Exam shows nuchal rigidity. What is the best next step?
Compare two SLE patients with acute confusion: one with fever and nuchal rigidity, and one who became psychotic after a major prednisone escalation—how does your diagnostic sequencing differ, and what “can’t-miss” etiologies change immediate management?
Q1: Is “lupus cerebritis” a distinct diagnosis with a specific test?
A: No. The ABIM-style expectation is that neuropsychiatric SLE is an attribution diagnosis supported by studies but not confirmed by any single test.
Q2: Why isn’t MRI considered confirmatory if it’s often abnormal?
A: Because MRI abnormalities (white matter lesions, infarcts) are nonspecific and overlap with APS thrombosis, infection, migraine, small vessel disease, and other inflammatory conditions—boards test specificity.
Q3: What is the role of lumbar puncture in suspected NPSLE?
A: Primarily to exclude infection and to gather supportive inflammatory data; it does not definitively establish NPSLE.
Q4: What competing diagnosis is especially board-relevant in SLE with stroke symptoms?
A: Antiphospholipid syndrome–related thrombosis; the ABIM expects you to distinguish thrombotic stroke from inflammatory NPSLE processes.
This question appears in Med-Challenger Internal Medicine Review with CME
Try for free and save. Ace your exams and meet your CME/MOC requirements for just $35 a month!
No matter your program, no matter the size, Med-Challenger for Groups and Institutions can better prepare your program or group, fulfill industry requirements, and increase test scores.
For personal medical education that includes board's prep, MOC, and CME requirements, Med-Challenger has you covered in Family Medicine, Emergency Medicine, Internal Medicine, Pediatrics, Pediatric Emergency Medicine, OBGYN, Physician Assistants, and Nurse Practitioners.